Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE: 002332)

Market Cap	12.50B
Revenue (ttm)	4.12B
Net Income (ttm)	621.66M
Shares Out	989.20M
EPS (ttm)	0.63
PE Ratio	20.08
Forward PE	18.19
Dividend	0.30 (2.38%)
Ex-Dividend Date	Jun 5, 2024

Volume	9,534,726
Open	13.14
Previous Close	12.78
Day's Range	12.56 - 13.14
52-Week Range	8.44 - 14.80
Beta	-0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 3,281
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002332

Financial Performance

In 2023, Zhejiang Xianju Pharmaceutical Co.,Ltd.'s revenue was 4.12 billion, a decrease of -5.85% compared to the previous year's 4.38 billion. Earnings were 563.08 million, a decrease of -24.86%.